Follow us for updates
© 2022
Read the Story →

Ayala Health Plans to Sell World's First Anti-COVID Pill in the Philippines

It's seeking FDA approval to import 300,000 doses.
by Pia Regalado
Nov 5, 2021
Photo/s: Merck

Ayala Corp's healthcare unit said Friday it was planning to import the world's first anti-COVID drug to the Philippines

Through MedEthix, AC Health said it was seeking clearance from the Food and Drug Authority to buy at least 300,000 doses of Merck's molnupiravir which would be sold in QualiMed hospitals, 

Continue reading below ↓

The pill is said to be most effective when taken during the early stages of infection, or within five days of the onset of symptoms. It can reduce the risk of hospitalization or death by 50%.

Molnupiravir can be taken at home to treat mild to moderate infections, AC Health said.

READ: Merck's COVID Pill Hailed After Cutting Hospitalizations by Half

Molnupiravir has yet to be cleared for emergency use in the Philippines and can only be administered on grounds of "compassionate use", to be determined by the FDA, Health Usec. Maria Rosario Vergeire said on Oct. 29.

So far, only the UK has approved the use of the anti-viral drug.

Continue reading below ↓
Recommended Videos

Reportr is now on Quento. Download the app or visit the Quento website for more articles and videos from Reportr and your favorite websites.

Latest Headlines
Read Next
Recent News
Some relief from rising prices.
With the reopening of several local destinations, this app has never been more timely.
Landmark Roe vs Wade ruling of 1973 is overturned.
Its rise mirrors the rise of technology for the masses.
It cites global uncertainties for its move.
The news. So what? Subscribe to the newsletter that explains what the news means for you.
The email address you entered is invalid.
Thank you for signing up to On Three, reportr's weekly newsletter delivered to your mailbox three times a week. Only the latest, most useful and most insightful reads.
By signing up to newsletter, you agree to our Terms of Service and Privacy Policy.